1887

Journal of General Virology header logo

Volume 96, Issue 10

Visualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging Free

Abstract

imaging can provide real-time information and three-dimensional (3D) non-invasive images of deep tissues and organs, including the brain, whilst allowing longitudinal observation of the same animals, thus eliminating potential variation between subjects. Current imaging technologies, such as magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT) and bioluminescence imaging (BLI), can be used to pinpoint the spatial location of target cells, which is urgently needed for revealing human immunodeficiency virus (HIV) dissemination in real-time and HIV-1 reservoirs during suppressive antiretroviral therapy (ART). To demonstrate that imaging can be used to visualize and quantify simian immunodeficiency virus (SIV)-transduced cells, we genetically engineered SIV to carry different imaging reporters. Based on the expression of the reporter genes, we could visualize and quantify the SIV-transduced cells via vesicular stomatitis virus glycoprotein pseudotyping in a mouse model using BLI, PET-CT or MRI. We also engineered a chimeric EcoSIV for infection study. Our results demonstrated that BLI is sensitive enough to detect as few as five single cells transduced with virus, whilst PET-CT can provide 3D images of the spatial location of as few as 10 000 SIV-infected cells. We also demonstrated that MRI can provide images with high spatial resolution in a 3D anatomical context to distinguish a small population of SIV-transduced cells. The imaging platform described here can potentially serve as a powerful tool to visualize lentiviral infection, including when and where viraemia rebounds, and how reservoirs are formed and maintained during latency or suppressive ART.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000245
2015-10-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/10/3131.html?itemId=/content/journal/jgv/10.1099/jgv.0.000245&mimeType=html&fmt=ahah

References

  1. Alexander L., Du Z., Rosenzweig M., Jung J.U., Desrosiers R.C. 1997; A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol 71:6094–6099[PubMed]
     [Google Scholar]
  2. Alexander L., Du Z., Howe A.Y., Czajak S., Desrosiers R.C. 1999a; Induction of AIDS in rhesus monkeys by a recombinant simian immunodeficiency virus expressing nef of human immunodeficiency virus type 1. J Virol 73:5814–5825[PubMed]
     [Google Scholar]
  3. Alexander L., Veazey R.S., Czajak S., DeMaria M., Rosenzweig M., Lackner A.A., Desrosiers R.C., Sasseville V.G. 1999b; Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys. AIDS Res Hum Retroviruses 15:11–21 [View Article][PubMed]
     [Google Scholar]
  4. Antoch G., Stattaus J., Nemat A.T., Marnitz S., Beyer T., Kuehl H., Bockisch A., Debatin J.F., Freudenberg L.S. 2003; Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533 [View Article][PubMed]
     [Google Scholar]
  5. Archibald S.L., Masliah E., Fennema-Notestine C., Marcotte T.D., Ellis R.J., McCutchan J.A., Heaton R.K., Grant I., Mallory M., other authors. 2004; Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol 61:369–376 [View Article][PubMed]
     [Google Scholar]
  6. Aylward E.H., Brettschneider P.D., McArthur J.C., Harris G.J., Schlaepfer T.E., Henderer J.D., Barta P.E., Tien A.Y., Pearlson G.D. 1995; Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152:987–994 [View Article][PubMed]
     [Google Scholar]
  7. Beaumont M., Odame I., Babyn P.S., Vidarsson L., Kirby-Allen M., Cheng H.L. 2009; Accurate liver T2* measurement of iron overload: a simulations investigation and in vivo study. J Magn Reson Imaging 30:313–320 [View Article][PubMed]
     [Google Scholar]
  8. Bulte J.W., Douglas T., Mann S., Frankel R.B., Moskowitz B.M., Brooks R.A., Baumgarner C.D., Vymazal J., Strub M.P., Frank J.A. 1994; Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J Magn Reson Imaging 4:497–505 [View Article][PubMed]
     [Google Scholar]
  9. Cherry S.R. 2006; Multimodality in vivo imaging systems: twice the power or double the trouble?. Annu Rev Biomed Eng 8:35–62 [View Article][PubMed]
     [Google Scholar]
  10. Choy G., O'Connor S., Diehn F.E., Costouros N., Alexander H.R., Choyke P., Libutti S.K. 2003; Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35:1022–1026[PubMed]
     [Google Scholar]
  11. Chun T.W., Davey R.T. Jr, Engel D., Lane H.C., Fauci A.S. 1999; Re-emergence of HIV after stopping therapy. Nature 401:874–875 [View Article][PubMed]
     [Google Scholar]
  12. Chung J.K. 2002; Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188–1200[PubMed]
     [Google Scholar]
  13. Cohen B., Dafni H., Meir G., Harmelin A., Neeman M. 2005; Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7:109–117 [View Article][PubMed]
     [Google Scholar]
  14. Deans A.E., Wadghiri Y.Z., Bernas L.M., Yu X., Rutt B.K., Turnbull D.H. 2006; Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med 56:51–59 [View Article][PubMed]
     [Google Scholar]
  15. Di Mascio M., Paik C.H., Carrasquillo J.A., Maeng J.S., Jang B.S., Shin I.S., Srinivasula S., Byrum R., Neria A., other authors. 2009; Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates. Blood 114:328–337 [View Article][PubMed]
     [Google Scholar]
  16. Dothager R.S., Flentie K., Moss B., Pan M.H., Kesarwala A., Piwnica-Worms D. 2009; Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol 20:45–53 [View Article][PubMed]
     [Google Scholar]
  17. Edinger M., Cao Y.-A., Hornig Y.S., Jenkins D.E., Verneris M.R., Bachmann M.H., Negrin R.S., Contag C.H. 2002; Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38:2128–2136 [View Article][PubMed]
     [Google Scholar]
  18. Eisele E., Siliciano R.F. 2012; Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37:377–388 [View Article][PubMed]
     [Google Scholar]
  19. Ernst T., Chang L., Jovicich J., Ames N., Arnold S. 2002; Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59:1343–1349 [View Article][PubMed]
     [Google Scholar]
  20. Evens N., Bormans G.M. 2010; Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography. Curr Top Med Chem 10:1527–1543 [View Article][PubMed]
     [Google Scholar]
  21. Fletcher C.V., Staskus K., Wietgrefe S.W., Rothenberger M., Reilly C., Chipman J.G., Beilman G.J., Khoruts A., Thorkelson A., Schmidt T.E. 2014; Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111:2307–2312 [CrossRef]
     [Google Scholar]
  22. Gambhir S.S., Barrio J.R., Wu L., Iyer M., Namavari M., Satyamurthy N., Bauer E., Parrish C., MacLaren D.C., other authors. 2003; Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med 39:2003–2011[PubMed]
     [Google Scholar]
  23. García F., Plana M., Vidal C., Cruceta A., O'Brien W.A., Pantaleo G., Pumarola T., Gallart T., Miró J.M., Gatell J.M. 1999; Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS 13:F79–F86 [View Article][PubMed]
     [Google Scholar]
  24. Genove G., DeMarco U., Xu H., Goins W.F., Ahrens E.T. 2005; A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11:450–454 [View Article][PubMed]
     [Google Scholar]
  25. Giavedoni L.D., Yilma T. 1996; Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J Virol 70:2247–2251
     [Google Scholar]
  26. Gibbs J.S., Regier D.A., Desrosiers R.C. 1994; Construction and in vitro properties of SIVmac mutants with deletions in ‘nonessential’ genes. AIDS Res Hum Retroviruses 10:607–616 [View Article][PubMed]
     [Google Scholar]
  27. Gottesfeld Z., Neeman M. 1996; Ferritin effect on the transverse relaxation of water: NMR microscopy at 9.4 T. Magn Reson Med 35:514–520 [View Article][PubMed]
     [Google Scholar]
  28. Gundlach B.R., Linhart H., Dittmer U., Sopper S., Reiprich S., Fuchs D., Fleckenstein B., Hunsmann G., Stahl-Hennig C., Uberla K. 1997; Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J Virol 71:2225–2232[PubMed]
     [Google Scholar]
  29. Guo H., Au W.Y., Cheung J.S., Kim D., Jensen J.H., Khong P.L., Chan Q., Chan K.C., Tosti C., other authors. 2009; Myocardial T2 quantitation in patients with iron overload at 3 Tesla. J Magn Reson Imaging 30:394–400 [View Article][PubMed]
     [Google Scholar]
  30. Guo Y., Ferdani R., Anderson C.J. 2012; Preparation and biological evaluation of 64Cu labeled Tyr3-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Bioconjug Chem 23:1470–1477 [View Article][PubMed]
     [Google Scholar]
  31. Harrigan P.R., Whaley M., Montaner J.S. 1999; Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 13:F59–F62 [View Article][PubMed]
     [Google Scholar]
  32. Hofmann-Lehmann R., Vlasak J., Williams A.L., Chenine A.-L., McClure H.M., Anderson D.C., O'Neil S., Ruprecht R.M. 2003; Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS 17:157–166 [View Article][PubMed]
     [Google Scholar]
  33. Iordanova B., Ahrens E.T. 2012; In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage 59:1004–1012 [View Article][PubMed]
     [Google Scholar]
  34. Johnson W.E., Desrosiers R.C. 2002; Viral persistence: HIV's strategies of immune system evasion. Annu Rev Med 53:499–518 [View Article][PubMed]
     [Google Scholar]
  35. Judenhofer M.S., Wehrl H.F., Newport D.F., Catana C., Siegel S.B., Becker M., Thielscher A., Kneilling M., Lichy M.P., other authors. 2008; Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 14:459–465 [View Article][PubMed]
     [Google Scholar]
  36. Kemp B.J., Hruska C.B., McFarland A.R., Lenox M.W., Lowe V.J. 2009; NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system. Phys Med Biol 54:2359–2376 [View Article][PubMed]
     [Google Scholar]
  37. Kestier H.W. III, Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., Desrosiers R.C. 1991; Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651–662 [View Article][PubMed]
     [Google Scholar]
  38. Kirsch W., McAuley G., Holshouser B., Petersen F., Ayaz M., Vinters H.V., Dickson C., Haacke E.M., Britt W. III, other authors. 2009; Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis 17:599–609[PubMed]
     [Google Scholar]
  39. Lecchi M., Ottobrini L., Martelli C., Del Sole A., Lucignani G. 2007; Instrumentation and probes for molecular and cellular imaging. Q J Nucl Med Mol Imaging 51:111–126[PubMed]
     [Google Scholar]
  40. Logothetis N.K., Guggenberger H., Peled S., Pauls J. 1999; Functional imaging of the monkey brain. Nat Neurosci 2:555–562 [View Article][PubMed]
     [Google Scholar]
  41. McArthur J.C. 2004; HIV dementia: an evolving disease. J Neuroimmunol 157:3–10 [View Article][PubMed]
     [Google Scholar]
  42. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., Mach R.H. 2006; PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050–1056 [View Article][PubMed]
     [Google Scholar]
  43. Neumann A.U., Tubiana R., Calvez V., Robert C., Li T.-S., Agut H., Autran B., Katlama C., Comet Study Group. 1999; HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. AIDS 13:677–683 [View Article][PubMed]
     [Google Scholar]
  44. Nischang M., Sutmuller R., Gers-Huber G., Audigé A., Li D., Rochat M.A., Baenziger S., Hofer U., Schlaepfer E., other authors. 2012; Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1. PLoS One 7:e38853 [View Article][PubMed]
     [Google Scholar]
  45. Patel Y.C. 1999; Somatostatin and its receptor family. Front Neuroendocrinol 20:157–198 [View Article][PubMed]
     [Google Scholar]
  46. Pfefferbaum A., Adalsteinsson E., Rohlfing T., Sullivan E.V. 2009; MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 47:493–500 [View Article][PubMed]
     [Google Scholar]
  47. Pöhlmann S., Stolte N., Münch J., Ten Haaft P., Heeney J.L., Stahl-Hennig C., Kirchhoff F. 1999; Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo . J Infect Dis 180:1494–1502 [View Article][PubMed]
     [Google Scholar]
  48. Potash M.J., Chao W., Bentsman G., Paris N., Saini M., Nitkiewicz J., Belem P., Sharer L., Brooks A.I., Volsky D.J. 2005; A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci U S A 102:3760–3765 [View Article][PubMed]
     [Google Scholar]
  49. Rabinovich B.A., Ye Y., Etto T., Chen J.Q., Levitsky H.I., Overwijk W.W., Cooper L.J., Gelovani J., Hwu P. 2008; Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A 105:14342–14346 [View Article][PubMed]
     [Google Scholar]
  50. Sawai E.T., Khan I.H., Montbriand P.M., Peterlin B.M., Cheng-Mayer C., Luciw P.A. 1996; Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr Biol 6:1519–1527 [View Article][PubMed]
     [Google Scholar]
  51. Sprague J.E., Peng Y., Sun X., Weisman G.R., Wong E.H., Achilefu S., Anderson C.J. 2004; Preparation and biological evaluation of copper-64-labeled Tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res 10:8674–8682 [View Article][PubMed]
     [Google Scholar]
  52. UNAIDS (2013) Global report: UNAIDS report on the global AIDS epidemic 2013. United Nations Joint Programme on HIV/AIDS (UNAIDS). http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf
  53. Velikyan I., Sundin A., Sörensen J., Lubberink M., Sandström M., Garske-Román U., Lundqvist H., Granberg D., Eriksson B. 2014; Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification. J Nucl Med 55:204–210 [View Article][PubMed]
     [Google Scholar]
  54. Venneti S., Bonneh-Barkay D., Lopresti B.J., Bissel S.J., Wang G., Mathis C.A., Piatak M. Jr, Lifson J.D., Nyaundi J.O., other authors. 2008; Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration. Am J Pathol 172:1603–1616 [View Article][PubMed]
     [Google Scholar]
  55. Vymazal J., Zak O., Bulte J.W., Aisen P., Brooks R.A. 1996; T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36:61–65 [View Article][PubMed]
     [Google Scholar]
  56. Vymazal J., Brooks R.A., Bulte J.W., Gordon D., Aisen P. 1998; Iron uptake by ferritin: NMR relaxometry studies at low iron loads. J Inorg Biochem 71:153–157 [View Article][PubMed]
     [Google Scholar]
  57. Wong J.K., Hezareh M., Günthard H.F., Havlir D.V., Ignacio C.C., Spina C.A., Richman D.D. 1997; Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291–1295 [View Article][PubMed]
     [Google Scholar]
  58. Yao B., Li T.Q., Gelderen P., Shmueli K., de Zwart J.A., Duyn J.H. 2009; Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44:1259–1266 [View Article][PubMed]
     [Google Scholar]
  59. Zhang X., Li C. 2013; Quantitative MRI measures in SIV-infected macaque brains. J Clin Cell Immunol Suppl 7:005
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000245
Loading
Visualization and quantification of simian immunodeficiency virus-infected cells using non-invasive molecular imaging
J. Gen. Virol. 96, 3131 (2015); https://doi.org/10.1099/jgv.0.000245
/content/journal/jgv/10.1099/jgv.0.000245
/content/journal/jgv/10.1099/jgv.0.000245
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error